Jennifer Tousignant serves as the Chief Legal Officer at Viridian Therapeutics, Inc., a position that underscores her extensive experience and leadership in the biotechnology and pharmaceutical industries. Prior to joining Viridian, Jennifer held significant roles at several high-profile companies, including serving as General Counsel at Akebia Therapeutics, where she played a pivotal role in guiding the company through various legal and regulatory challenges. Her career also includes a notable tenure at Ironwood Pharmaceuticals, where she was instrumental in navigating complex legal landscapes and fostering strategic growth. At Viridian Therapeutics, Jennifer's role as Chief Legal Officer involves overseeing all legal aspects of the company's operations, including intellectual property management, compliance, and corporate governance. Her strategic vision and legal acumen have been crucial in steering Viridian through its growth phases, particularly as the company advances its portfolio of innovative treatments for serious diseases. Jennifer's leadership is characterized by her ability to integrate legal strategies with business objectives, ensuring that Viridian remains at the forefront of the biotechnology sector while adhering to the highest standards of ethical and legal conduct. Jennifer's achievements extend beyond her corporate roles; she is also recognized for her contributions to the broader legal and biotech communities. She frequently speaks at industry conferences and has been involved in various professional organizations, advocating for advancements in legal practices within the life sciences sector. Her dedication to fostering a culture of integrity and innovation at Viridian has not only enhanced the company's legal framework but has also contributed significantly to its overall mission of improving patient outcomes through cutting-edge therapies.